(Brussels Comprehensive) In order to ensure the supply of coronary vaccines within the European Union, the European Commission starts an emergency plan and can prohibit vaccine exports produced in the European Union if necessary.The EU's move is worrying that it will trigger the global battle of coronary vaccine.

EU Vice Chairman Dongbolovskis told reporters on Friday that this is an extremely urgent emergency measure to ensure that the EU vaccine can be delivered on time."We have invested funds to increase the output of these vaccine manufacturers. Now, we hope that manufacturers can fulfill their delivery commitments."

The

This control plan is implemented for six weeks, and it is expected to continue at least at the end of March.

The World Health Organization criticized the EU's approach, saying that it may lead to "a very worrying trend" and may endanger the supply chain of the global crown vaccine.

Xi Mang, Assistant Director of the WHO, said that at this time, the restrictions on or hindering exports at this time will cause the supply of vaccines, diagnostic materials and other medicines to be freely circulated, which will not be conducive to the crown disease epidemic.

It is known that this plan is only aimed at the procurement contract signed by the European Commission with the pharmaceutical company.These companies in the European Union must apply to the European Union if they want to export vaccines to the European Union.They must also show the export records of the previous three months.The European Union originally intended to quote the emergency clauses of the Brexit Agreement, which restricted the vaccine to the northern Ireland by the Irish border to Northern Ireland.

However, the European Union warned that as long as the vaccine or active substances were shipped out of the European Union, it would use "all available tools" to stop it.

The European Union has recently been unhappy with the problem of insufficient vaccine delivery with Astraikon.The European Union has accused Astraik as delaying delivery and violating procurement contracts with the European Union, but it can perform contracts with Britain and deliver them on time.

The Chairman of the European Council Michelle recently wrote a letter to some members of the EU member states, saying that the EU must explore various legal channels to ensure that once the negotiations with the pharmaceutical company failed, they could still obtain due vaccine supply.

Analysis: EU controls vaccine exports may trigger global vaccine battle

Bloomberg analysis pointed out that the EU's strict implementation of coronary vaccine export control may trigger the global vaccine battle, leading countries to increase their efforts to grab the crown vaccine.The President of Pfizer, the United States Pharmaceutical Factory, warned that the EU's practice of trying to interfere with the global crown vaccine supply chain will bring a negative effect.

Aberle said at the group seminar on the World Economic Forum on Friday: "I am worried that this will form a dual -losing situation and will not be the victory of Europe.Product export or restrictions, which will cause a bad situation, which is not good for everyone. "